Stocks›Healthcare›INCY

INCY

INCYTE CORPORATION
NasdaqResearch view
$123.89−0.44%
Sep 25 close · 1D EOD · Databento
HealthcareServices-Commercial Physical & Biological ResearchLarge-capSEC EDGAR FY 2025-12-31

The numbers · FY2025, filed

SEC EDGAR
Market cap$25.1B
Revenue$5.1B+21.20%
Net income$1.3B
EPS, diluted$6.41+4173.30%
Operating margin29.5%
Return on equity24.9%
All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31
SectorHealthcare
Market Cap$25.1B
Enterprise Value$41.0B
Income$1.3B
Sales$5.1B
Book/sh$25.87
Cash/sh$15.52
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio3.25
Current Ratio3.32
Debt/Eq3.68
EPS (ttm)$6.41
EPS this Y4173.3%
EPS past 3/5Y61.6%
Sales past 3/5Y14.8%
EPS Y/Y TTM4173.3%
Sales Y/Y TTM21.2%
Shs Outstand199.78M
ROA18.5%
ROE24.9%
ROIC5.6%
Gross Margin—
Oper. Margin29.5%
Profit Margin25.0%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$3.0B
FY21
$3.4B
FY22
$3.7B
FY23
$4.2B
FY24
$5.1B
FY25

Operating leverage — margins

GrossOperatingNet
0%40%80%29%25%FY21FY22FY23FY24FY25
Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2021FY2022FY2023FY2024FY2025

Same industry

In the screener →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.